Invitation to Newron’s full year results presentation; Zurich , Tuesday, 19 March 2013 Freitag, 08. März 2013 - 10:00

Dear Madam or Sir,

Newron Pharmaceuticals S.p.A. (SIX:NWRN), a research and development company focused on novel Central Nervous System (CNS) and pain therapies, invites you to a media and analyst conference in Zurich.

The management team will present the full year results and provide an update and guidance for the development of Newron’s R&D pipeline, including Safinamide phase III results presented at the AAN Annual Meeting on the 18th of March. Please note that the presentations will be in English.

There will be a simultaneous conference call.

We kindly ask you to confirm your attendance by filling in and sending back the following registration form to IRF Communications by 15 March 2013. For further details, please contact Vanessa Winter, newron@irfcom.ch, Phone +41 43 244 81 55.

We look forward to welcoming you at the conference.